Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Obese patients with atrial fibrillation are more efficiently protected from thrombosis under warfarin or xabans compared to non-obese patients; a systematic review and Meta-analysis of six randomized controlled trials.
Karatisidis L, Zagoridis K, Mprotsis T, Misidou C, Pentidou A, Vrachiolias G, Bezirgianidou Z, Kontomanolis E, Spanoudakis E. Karatisidis L, et al. Among authors: mprotsis t. Thromb Res. 2024 Jun;238:88-96. doi: 10.1016/j.thromres.2024.04.022. Epub 2024 Apr 24. Thromb Res. 2024. PMID: 38696925
A randomized, observer-blind, vehicle-control, multi-center clinical investigation for assessing the efficacy and tolerability of a 1% ectoine and hyaluronic acid 0.1%-containing medical device in pediatric patients with mild-to-moderate atopic dermatitis.
Alexopoulos A, Dakoutrou M, Nasi L, Thanopoulou I, Kakourou T, Kontara L, Douladiris N, Galani M, Xepapadaki P, Doxani C, Mprotsis T, Zintzaras E, Papadopoulos NG, Kanaka-Gantenbein C, Chrousos GP. Alexopoulos A, et al. Among authors: mprotsis t. Pediatr Dermatol. 2023 Jan;40(1):78-83. doi: 10.1111/pde.15117. Epub 2022 Aug 29. Pediatr Dermatol. 2023. PMID: 36038984 Clinical Trial.
Assessment of the relative effectiveness and tolerability of treatments of type 2 diabetes mellitus: a network meta-analysis.
Zintzaras E, Miligkos M, Ziakas P, Balk EM, Mademtzoglou D, Doxani C, Mprotsis T, Gowri R, Xanthopoulou P, Mpoulimari I, Kokkali C, Dimoulou G, Rodopolou P, Stefanidis I, Kent DM, Hadjigeorgiou GM. Zintzaras E, et al. Among authors: mprotsis t. Clin Ther. 2014 Oct 1;36(10):1443-53.e9. doi: 10.1016/j.clinthera.2014.06.035. Epub 2014 Aug 8. Clin Ther. 2014. PMID: 25109773
A network meta-analysis of randomized controlled trials for comparing the effectiveness and safety profile of treatments with marketing authorization for relapsing multiple sclerosis.
Hadjigeorgiou GM, Doxani C, Miligkos M, Ziakas P, Bakalos G, Papadimitriou D, Mprotsis T, Grigoriadis N, Zintzaras E. Hadjigeorgiou GM, et al. Among authors: mprotsis t. J Clin Pharm Ther. 2013 Dec;38(6):433-9. doi: 10.1111/jcpt.12090. Epub 2013 Aug 20. J Clin Pharm Ther. 2013. PMID: 23957759 Review.